Last update 09 Aug 2025

Ibuprofen/Guaifenesin/Dextromethorphan Hydrobromide Hydrate/DL-Methylephedrine Hydrochloride/Bromhexine Hydrochloride

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Maxibupen, 맥시부펜코프연질캡슐
Target
COX-1 x COX-2 x NMDA receptor x adrenergic receptor x σ1 receptor
Action
inhibitors, antagonists, agonists
Mechanism
COX-1 inhibitors(Cyclooxygenase-1 inhibitors), COX-2 inhibitors(Cyclooxygenase-2 inhibitors), NMDA receptor antagonists(Glutamate [NMDA] receptor antagonists)
Therapeutic Areas
Infectious DiseasesRespiratory Diseases
Active Indication
Common Cold
Inactive Indication-
Originator Organization
Hanmi Pharmaceutical Co., Ltd.Hanmi Pharmaceutical Co., Ltd.
Active Organization
Hanmi Pharmaceutical Co., Ltd.Hanmi Pharmaceutical Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhaseApproved
First Approval Date
South Korea (06 Aug 2025),
Common Cold
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC11H17NO
InChIKeyFMCGSUUBYTWNDP-ONGXEEELSA-N
CAS Registry552-79-4
View All Structures (7)

Related

100 Clinical Results associated with Ibuprofen/Guaifenesin/Dextromethorphan Hydrobromide Hydrate/DL-Methylephedrine Hydrochloride/Bromhexine Hydrochloride
Login to view more data
100 Translational Medicine associated with Ibuprofen/Guaifenesin/Dextromethorphan Hydrobromide Hydrate/DL-Methylephedrine Hydrochloride/Bromhexine Hydrochloride
Login to view more data
100 Patents (Medical) associated with Ibuprofen/Guaifenesin/Dextromethorphan Hydrobromide Hydrate/DL-Methylephedrine Hydrochloride/Bromhexine Hydrochloride
Login to view more data
100 Deals associated with Ibuprofen/Guaifenesin/Dextromethorphan Hydrobromide Hydrate/DL-Methylephedrine Hydrochloride/Bromhexine Hydrochloride
Login to view more data

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Common Cold
South Korea
Hanmi Pharmaceutical Co., Ltd.Hanmi Pharmaceutical Co., Ltd.
06 Aug 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free